The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy

Pediatrics

Volumn 103, Issue 3, 1999, Pages 588-593

  Rättyä, Johanna ^a   Vainionpa, Leena ^a   Knip, Mikael ^a   Lanning, Peter ^a   Isojärvi, Jouko I T ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Antiepileptic drugs; Epilepsy; Girls; Growth; Insulin; Insulin like growth factor binding proteins 1 and 3; Insulin like growth factor I; Sexual maturation

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; INSULIN; OXCARBAZEPINE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CHILD GROWTH; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; FEMALE; GROWTH CURVE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEXUAL MATURATION; WEIGHT GAIN;

EID: 0343445201     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.3.588     Document Type: Article

References (25)

1. Webber MP, Hauser WA, Ottman R, Angeners JF. Fertility in persons with epilepsy: 1935-1974. Epilepsia. 1968;27:746-752
2. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia. 1995;36:353-357
3. Herzog AG. Temporolimbic brain dysfunction - role in reproductive endocrine disorders. Fertil Steril. 1996;65:210-211
4. Mattson RH, Cramer JA. Epilepsy, sex hormones, and antiepileptic drugs. Epilepsia. 1985;26:40-51
5. Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol. 1996;39:579-584
6. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;4:1383-1388
7. Isojärvi JIT, Rättya J, Myllylä VV, Knip M, Koivunen R, Tapanainen J. Valproate, lamotrigine and insulin mediated risks in women with epilepsy. Ann Neurol. 1998;43:446-451
8. Styne DM. Physiology of puberty. In: Brook CGD, ed. Clinical Paediatric Endocrinology. Oxford, England: Blackwell Scientific Publications; 1995: 234-252
9. Isojärvi JIT, Pakarinen AJ, Myllylä W. Thyroid function with antiepileptic drugs. Epilepsia. 1992;33:142-148
10. Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. Br Med J. 1981;29:577-581
11. Easter D, O'Bryan-Tear CG, Verity C. Weight gain with valproate or carbamazepine - a reappraisal. Seizure. 1997;6:121-125
12. Isojärvi JIT, Pakarinen AJ, Myllylä VV. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol. 1989;46:1175-1178
13. Isojärvi JIT, Repo M, Pakarinen AJ, Lukkarinen O, Myllylä VV. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia. 1995;36:366-370
14. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia. 1995;36:676-681
15. Isojärvi JIT, Pakarinen AJ, Rautio A, Pelkonen O, Myllylä VV. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Eur J Clin Pharmacol. 1995;47:461-464
16. Isojärvi JIT, Airaksinen KE, Mustonen JN, Pakarinen AJ, Rautio A, Pelkonen O. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia. 1995;36:810-816
17. Proposal for revised classification of epilepsies and epileptic syndromes: From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30:389-399
18. Murphy JV. Valproate monotherapy in children. Am J Med. 1988;25: 17-22
19. Sorva R, Perheentupa J, Tolppanen E-M. A novel format for growth chart. Acta Paediatr Scand. 1984;73:527-529
20. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press; 1959
21. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity and stages of puberty. Arch Dis Child. 1976;51: 170-182
22. Keränen T, Jolkkonen J, Klosterskov Jensen P. Single-dose kinetics of oxcarbazepine after treatment with cimeridine or erythromycin. Epilepsia. 1990;31:641
23. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578-582
24. Andrade Olivie MA, Garcia-Mayor RV, Gonzalez Leston D, et al. Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study. Pediatr Res. 1995;38:149-155
25. Coiro V, Capretti L, Bianconi L. Reduction of baclofen-but not sodium valproate-induced growth and hormone release in type I diabetic men. Horm Metab Res. 1991;23:600-604